Glucophage

Glucophage is a prescription medication that contains the active ingredient metformin hydrochloride, a biguanide class drug used orally to manage blood glucose levels. It is marketed in the European Union and is commonly prescribed for adults with type 2 diabetes mellitus. The formulation is designed to be taken by mouth, and it works by influencing hepatic glucose production and insulin sensitivity.

Glucophage is indicated for the management of type 2 diabetes mellitus as part of a comprehensive treatment plan that includes diet and exercise.

- Improves glycemic control in adults with type 2 diabetes. - Can be used as monotherapy when diet and exercise alone are insufficient. - May be combined with other antidiabetic agents for enhanced effect. - Sometimes prescribed off‑label for polycystic ovary syndrome (PCOS) under medical supervision. - Utilized in clinical practice to reduce cardiovascular risk factors associated with diabetes.

Glucophage may cause a range of side effects, most of which are mild and transient. Serious adverse reactions are less common but require prompt medical attention.

Common: - Gastrointestinal upset such as nausea, diarrhea, or abdominal discomfort. - Metallic taste in the mouth. - Decreased appetite. - Mild headache. - Weight loss or reduced body weight.

Serious: - Lactic acidosis, a rare but potentially life‑threatening condition. - Severe hypoglycemia when combined with insulin or sulfonylureas. - Hepatotoxicity indicated by jaundice or elevated liver enzymes. - Allergic reactions including rash, itching, or swelling.

Before starting Glucophage, certain health considerations should be reviewed with a healthcare professional.

- Assess kidney function; contraindicated in severe renal impairment. - Evaluate liver function, as hepatic disease may increase risk of lactic acidosis. - Use cautiously in patients with heart failure or a history of cardiovascular disease. - Monitor vitamin B12 levels during long‑term therapy, as deficiency can occur. - Discontinue before any radiographic studies involving iodinated contrast agents. - Pregnancy and breastfeeding decisions should be made in consultation with a physician.

Glucophage can interact with several medications, affecting its efficacy or safety profile.

Avoid: - Iodinated contrast media used in imaging studies, due to increased risk of renal dysfunction. - Alcohol excess, which may potentiate lactic acidosis. - Cimetidine, which can raise metformin plasma concentrations.

Use with caution: - Other antidiabetic agents (e.g., insulin, sulfonylureas) that increase hypoglycemia risk. - Diuretics that may affect renal function. - Corticosteroids, which can raise blood glucose levels. - ACE inhibitors or ARBs, requiring monitoring of renal function.